why choose us

First received: May 02, 2023

Clinical Trial: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Severe Hypertriglyceridemia

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia (SHTG): The ENTRUST Study

Brief Summary: To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ?500 to ?2000 mg/dL) after 26 weeks of treatment.

Read more